| Financial Year |
March 31 2023 |
| Monetary Funds |
691,951,029.49 |
| Held-for-trading Financial Assets |
63,157,324.89 |
| Notes Receivable |
28,440,166.74 |
| Accounts Receivable |
464,526,631.19 |
| Advances to Suppliers |
20,415,457.11 |
| Other Receivables |
14,162,463.64 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
245,295,778.50 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
34,027,997.52 |
| Total Current Assets |
1,878,017,269.38 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
857,625,427.51 |
| Investment Properties |
-- |
| Fixed Assetes |
649,538,603.37 |
| Under-construction Projects |
68,428,457.30 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
218,572,431.77 |
| R&D expenses |
-- |
| Goodwill |
1,360,378.48 |
| Long-Term Deferred and Prepaid Expenses |
322,955.96 |
| Deferred Income Tax Assets |
23,198,603.61 |
| Other Non-Current Assets |
49,345,022.67 |
| Sub-Total of Non-Current Assets |
1,877,929,614.88 |
| Total Assets |
3,755,946,884.26 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
-- |
| Accounts Payable |
146,876,541.38 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
42,951,029.06 |
| Taxes Payable |
34,331,345.61 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
26,515,140.08 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
5,449,278.42 |
| Other Current Liabilities |
435,685.91 |
| Sub-Total of Current Liabilities |
257,902,612.15 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
-- |
| Special Payable |
-- |
| Estimatied Liabilities |
-- |
| Deferred Income Tax Liabilities |
38,893,181.93 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
93,555,981.87 |
| Total Liabilities |
351,458,594.02 |
| Paid-In Capital(Or Share Stock) |
320,541,556.00 |
| Capital Surplus |
1,485,716,877.79 |
| Surplus Reserve |
160,270,778.00 |
| LESS:Treasury Stock |
60,021,002.12 |
| Undistributed Profits |
1,302,932,520.20 |
| Minority Stockholder's Interest |
194,544,518.51 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
3,209,943,771.73 |
| Owner's Equity（Stockholder's Equity） |
3,404,488,290.24 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,755,946,884.26 |
